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Bayés syndrome is an under-recognized clinical condition characterized by inter-atrial
block (IAB). This is defined electrocardiographically as P-wave duration > 120ms and
can be categorized into first, second and third degree IAB. It can be caused by
inflammatory conditions such as systemic sclerosis and rheumatoid arthritis, abnormal
protein deposition in cardiac amyloidosis, or neoplastic processes invading the inter-atrial
conduction system, such as primary cardiac lymphoma. It may arise transiently during
volume overload, autonomic dysfunction or electrolyte disturbances from vomiting. In
other patients without an obvious cause, the predisposing factors are diabetes mellitus,
hypertensive heart disease, and hypercholesterolemia. IAB has a strong association
with atrial arrhythmogenesis, left atrial enlargement (LAE), and electro-mechanical
discordance, increasing the risk of cerebrovascular accidents as well as myocardial and
mesenteric ischemia. The aim of this review article is to synthesize experimental evidence
on the pathogenesis of IAB and its underlying molecular mechanisms. Current medical
therapies include anti-fibrotic, anti-arrhythmic and anti-coagulation agents, whereas
interventional options include atrial resynchronization therapy by single or multisite
pacing. Future studies will be needed to elucidate the significance of the link between IAB
and atrial tachyarrhythmias in patients with different underlying etiologies and optimize
the management options in these populations.
Keywords: Bayés syndrome, inter-atrial block, intra-atrial block, conduction, electrophysiological remodeling,
structural remodeling
INTRODUCTION
The first case of inter-atrial block (IAB) was first described by Bachmann (1941), who recognized
the significance of P-wave splitting on the ECG, some 25 years after he described the anatomy
of Bachmann’s bundle (Bachmann, 1916). Dr Bayés de Luna was the first who provided a clear
description of atrial conduction block in 1979, classifying them into either inter- and intra-atrial
(Bayés de Luna, 1979). In recognition of his numerous contributions to the understanding of IAB
(Bayes de Luna et al., 1985), this disease was later named Bayés syndrome (Conde and Baranchuk,
2014).
The cardiac conduction system starts at the sinoatrial node, which is the pacemaker responsible
for initiating action potentials (APs) that are conducted through the right atrium via three distinct
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inter-nodal pathways to the atrioventricular node. These are the
anterior, middle (Wenckebach) and posterior (Thorel) pathways
(Figure 1; Conde et al., 2015). Inter-atrial conduction from the
right to left atrium occurs most frequently along Bachmann’s
bundle, which branches from the anterior internodal pathway
(James, 1963; Racker, 1989), but it can also pass through the
coronary sinus or the fossa ovalis (Tapanainen et al., 2009).
IAB is caused by impaired conduction along Bachmann’s
bundle. Two definitions of IAB have been proposed. The
classification adopted in the consensus report divides it into
either partial (P wave duration > 120ms) or advanced (P wave
duration > 120ms with biphasic morphology in the inferior
leads; Bayés de Luna, 1979). Alternatively, similar to sinoatrial or
atrioventricular block, it can be divided into first (partial), second
(first degree with intermittent conduction through Bachmann’s
bundle) or third degree (advanced; Figure 2; Bayes de Luna
et al., 2012; Chhabra et al., 2014). Partial or first degree IAB is
characterized by prolonged P wave duration of >120 ms, with
bifid (notching) with dome-and-spike morphology on the ECG.
The definition of a normal P-wave duration is a contentious issue
because 120ms has been considered by some clinicians to be
normal, yet the upper limit was defined by the World Health
Organization and the International Society and Federation of
Cardiology Task Force to be 110ms (Willems et al., 1985). This
may arise from difficulty in accurately measuring the P-wave
duration (Baranchuk et al., 2016), which is in part due to baseline
noise (Magnani et al., 2010). Intra- and inter-observer variability
also contributes to inconsistent reported values (Dilaveris et al.,
1999). Nevertheless, for first degree or partial IAB, a recent
consensus report agreed on the definition of P-wave duration >
120ms (Bayes de Luna et al., 2012). This is in keeping with a
previous study demonstrating the modal P-wave duration to be
120ms in first-degree IAB (Ariyarajah et al., 2006b).
In second degree IAB, the P-wave shows an initial invariant
component but a second component with varying morphology
within the same ECG. This is commonly seen in atrial aberrancy
(Chung, 1970), with concealed atrial conduction from post-
ectopic inhibition (Chung’s phenomenon; Chung and Chung,
1972). Bachmann’s bundle has a long effective refractory period
(ERP; Vollmann et al., 2005), during which Na+ channels
cannot be reactivated. Therefore, a premature AP will not be
able to pass through this bundle, but has to take another and
potentially longer path. Second degree IAB can occur in an
absence of a premature atrial beat. A limitation of the definition
of second degree IAB is that to diagnose intermittent conduction
through Bachmann’s bundle, a constant interval between two
P-waves is needed. If this interval is not constant, then it is
possible that variable morphologies can be explained by APs with
different initiation sites, for example, opposite sides of the crista
terminalis.
In advanced or third degree IAB, there is a biphasic P-wave
in the inferior leads with a negative terminal deflection below
the isoelectric line. As conduction via Bachmann’s bundle is
completely blocked, the AP wave must pass through another
pathway, such as the coronary sinus. This may result in
retrograde activation of the left atrium in the caudo-cranial
direction, producing a negative terminal deflection (Bayes de
Luna et al., 1988; Cosio et al., 2004). However, if the wave passes
through the rim of the fossa ovalis, then retrograde activation
may not necessarily occur.
Advanced IAB is clinically important as there is a high chance
of developing supraventricular tachycardia if it is left untreated
(Bayes de Luna et al., 1999). Left atrial enlargement (LAE) is
often associated with, but should be distinguished from, IAB
(Mehrzad and Spodick, 2014). LAE leads to prolonged inter-atrial
conduction times because of increased stretch and lengthening
of Bachmann’s bundle (Boineau, 2005). This delay is due to
increased distance of conduction rather than block in the bundle
per se. In the inferior leads, there are biphasic P-waves but
without the terminal negative deflections seen in third degree
IAB. LAE can be diagnosed on the ECG by a biphasic P-wave on
V1 together with an area under the curve for the second phase
<40mm.ms (Chhabra et al., 2014).
The prevalence of IAB is age-dependent, increasing from
5.4% at <20 years old to 60% at >50 (Jairath and Spodick,
2001; Asad and Spodick, 2003; Ariyarajah et al., 2005; Gialafos
et al., 2007; Martinez-Selles et al., 2016b). This is likely
the result of aging-related fibrosis, which would result in
impaired AP conduction through the atria (Gramley et al.,
2009; Fleg and Strait, 2012). The risk factors for developing
IAB are coronary artery disease, hypertension, diabetes mellitus
and hypercholesterolemia (Figure 3; Ariyarajah et al., 2006a).
IAB can be caused by structural defects of the conducting
pathway, such as atrial septal defect (Thilen et al., 2007)
or aneurysm (Okutucu et al., 2010), or infiltration of the
bundle from cardiac lymphoma (Engelen et al., 2005; Peyrou
et al., 2013) or amyloidosis (Rocken et al., 2002). Alternatively,
inflammation can induce cardiac structural remodeling, which
can occur in hypertrophic cardiomyopathy (Szili-Torok et al.,
2014) or systemic inflammatory diseases such as scleroderma
and rheumatoid arthritis (Mizuno et al., 1999; Acar et al.,
2009). Transient IAB may be related to autonomic dysfunction,
increased atrial strain or electrolyte abnormalities. For example,
it was observed in decompensated heart failure with increased
atrial strain from volume overload, which disappeared after its
resolution using diuretic therapy (Song et al., 2002; Proietti
et al., 2012), or hemodialysis patients with vomiting (Enriquez
et al., 2015). In terms of disease progression, it takes around
66 months to progress from a normal P-wave duration to
advanced IAB (Ariyarajah et al., 2007b). IAB is important
because of increased risks of atrial arrhythmias (tachycardia,
flutter, fibrillation) complicated by LAE and electro-mechanical
discordance (Ariyarajah et al., 2007a). This predisposes to
increased thrombosis in obstructive sleep apnea (Can et al.,
2009; Cagirci et al., 2011; Maeno et al., 2013) and to myocardial
ischemia (Myrianthefs et al., 1991), cerebral vascular accidents
(Lorbar et al., 2005), and mesenteric ischemia (Chhabra et al.,
2012).
IAB can be managed with pharmacological therapy, such
as angiotensin-converting enzyme (ACE) inhibitors, which
can delay the progression from first degree to third degree
IAB (Ariyarajah et al., 2007b). It can also be managed by
interventional procedures, such as multi-site or single site
pacing at the triangle of Koch or Bachmann’s bundle. It is
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FIGURE 1 | Conduction of action potentials from the sinoatrial node across the right atrium to the atrioventricular node occurs via three inter-nodal
tracts. Conduction from the right atrium to the left atrium occurs via Bachmann’s bundle.
unclear whether there is any benefit in early treatment. Atrial
resynchronization therapy can be used to correct for left-sided




To understand the electrophysiological mechanisms of IAB and
how it increases atrial arrhythmic risk, the determinants of AP
conduction through the myocardium must first be considered
(Kléber and Rudy, 2004; Tse and Yeo, 2015; Tse et al., 2016b).
This can be described by the core conduction theory (Barr
et al., 2003). Conduction velocity (CV) depends on both passive
and active electrical properties. Passive properties refer to
the resistive and capacitive components and the architecture
of the myocardium. They include the axial resistance (ri)
of both the myoplasm (Thomas et al., 2003) and the gap
junctions between cardiomyocytes (Rohr et al., 1998; Chen
et al., 2007), resistance of the extracellular space (ro), and the
membrane capacitance (Cm). Active membrane properties refer
to the voltage-gated ionic conductances: the most important
conductance is that of Na+ channels, which mediates INa
and determine the AP upstroke. Reduced CV can arise from
increased ri, ro or Cm, decreased maximum upstroke velocity
(dV/dtmax, from reduced Na
+ current density, Nattel, 2008;
Tse et al., 2016g) or decreased myocardial excitability given by
1/(Threshold Potential–Resting Membrane Potential). Cardiac
fibrosis can decrease CV by the following mechanisms: reduced
cardiomyocyte-cardiomyocyte coupling, which increases ri, or
increased fibroblast-cardiomyocyte coupling, which increases
Cm (Tse and Yeo, 2015). Moreover, fibroblast-cardiomyocyte
coupling can depolarize cardiomyocytes (Rohr, 2012; Kohl and
Gourdie, 2014; Thomsen and Calloe, 2016), leading to Na+
channel inactivation and reduced dV/dtmax. It is increasingly
recognized that passive and active properties are not independent
of each other, since gap junctions and Na+ channels co-localize
in the connexome, and their close proximity to each other
could enable ephaptic conduction (Rhett and Gourdie, 2012;
Veeraraghavan et al., 2012, 2014a,b,c, 2015; Rhett et al., 2013;
George et al., 2015). Increased risk of arrhythmogenesis by either
circus-type or spiral wave reentry can be explained by a reduction
in excitation wavelength (λ) given by CV × ERP (Wiener and
Rosenblueth, 1946; Smeets et al., 1986; Vaidya et al., 1999; Tse,
2015; Tse et al., 2016f, in press). Selective atrial fibrosis could
increase the heterogeneity of conduction by allowing micro-
reentry to take place in smaller areas in atrial fibrosis (Spach and
Josephson, 1994; Verheule et al., 2004).
Inter-Atrial Block Can Arise from Abnormal
Function or Expression of Sodium
Channels and Gap Junctions
The conditions predisposing or causing IAB can affect any of
these parameters. Animals have been extensively used to study
cardiac arrhythmogenesis in a number of clinical conditions
because of their amenability to genetic and pharmacological
manipulation (Chen et al., in press; Choy et al., 2016).
In these systems, electrical activity can be recorded using
different techniques such as monophasic action potential and
bipolar electrogram methods, optical mapping and surface
electrocardiography (Vigmond and Leon, 1999; van Rijen
et al., 2001; Vigmond, 2005; Vigmond et al., 2009; Tse et al.,
2016c,h). Although few mouse models have been generated
specifically for studying IAB, experiments in different systems
have increased our understanding on themolecular determinants
of AP conduction (Tse et al., 2012, 2016d,e,i; George et al.,
2015; Veeraraghavan et al., 2015) and how abnormalities in
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FIGURE 2 | Normal inter-atrial conduction (A), partial (B), and advanced
(C) inter-atrial block (IAB), with distinct electrocardiographic findings.
IAB should be distinguished from left atrial enlargement (LAE) (D), where there
is conduction delay from lengthening of Bachmann’s bundle in the absence of
block.
ion channels or cardiac remodeling lead to intra- or inter-atrial
conduction defects (Figure 4).
Conduction between successive cardiomyocytes occurs via
gap junctions. Each gap junction consists of two connexons,
each of which is a hexamer of proteins called connexins (Cx).
Cx40 and 43 are the isoforms expressed in the atria (Beyer et al.,
1987; Gourdie et al., 1993a,b). Cx40−/− mice showed intra-atrial
conduction delay (Hagendorff et al., 1999; Verheule et al., 1999).
Mice with cardiomyocyte-directed expression of CREM-Ib1C-
X, an isoform of transcription factor CREM (Kirchhof et al.,
2013), showed evidence of fibrosis, atrial dilatation and IAB,
associated with downregulation of Cx40 and ryanodine receptor
2 (RyR2)-mediated Ca2+ leak from the sarcoplasmic reticulum
(Li et al., 2014). Increased leak could have a knock on effect by
downregulating Na+ channels and decreasing INa (Curran and
Louch, 2015).
Liver kinase B1, which has been termed the master
upstream kinase, normally activates AMP-activated protein
kinase (AMPK) and other related kinases (Gan and Li, 2014). Its
deletion led to downregulation of both Cx40 and Na+ channels,
resulting in complete absence of inter-atrial conduction (Kim
et al., 2015). This was later complicated by atrial enlargement
and fibrosis without inflammation, hypertrophy or apoptosis.
Interestingly, mice with knockout of regulator of G-protein
signaling 5 (Rgs5−/−), a negative regulator of G protein-
mediated signaling, showed increased P-wave duration in the
absence of atrial dilatation or fibrosis (Qin et al., 2012). These two
experiments on mouse model support the notion that although
IAB and LAE frequently co-exist, they have different underlying
pathologies.
Increased Oxidative Stress,
Renin-Angiotensin System Activation and
IAB
For cardio-metabolic disorders such as hypertension and
diabetes, the common link appears to involve increased reactive
oxygen species (ROS) production leading to excess oxidative
stress (Tse et al., 2016a; Zhang et al., 2016). In hypertension,
there is increased renin-angiotensin system (RAS) activation with
elevated levels of angiotensin II (Murugan et al., 2015; Zhang
et al., 2015). Mice infused with angiotensin II showed inter-atrial
conduction delay, which was dependent on the leptin signaling
pathway (Fukui et al., 2013). This resulted in upregulation of
transforming growth factor beta, Monocyte Chemoattractant
Protein-1 and RANTES, ultimately leading to fibrosis from
deposition of collagen types 1 and 3. Ang-II has been shown
to mediate cardiac fibrosis and inflammation via the Smad/NF-
κB pathway (Wei et al., 2013). NF-κB can bind to the promoter
region of the gene encoding for the Na+ channel (Shang and
Dudley, 2005) to reduce its transcriptional activity (Shang et al.,
2008).
Moreover, cardiac-restricted ACE overexpression produced
conduction defects and reduced expression of atrial connexin
40 (Cx40) and connexin 43 (Cx43) proteins. Activation of
the AT1 receptor by Ang-II stimulates Nox2 to generate
oxygen free radicals, which can diffuse to and promote
further ROS release at the mitochondria, by activation
of the mitochondrial permeability transition (MPT) to
mediate ROS-induced ROS release (RIRR; Zorov et al.,
2000). Mitochondrial ROS can decrease the expression
of Cx43 via c-src activation (Sovari et al., 2013), as well
as induce myocardial fibrosis via NOX4/MAPK signaling
(Aragno et al., 2006; Kuroda et al., 2010). Diabetes produces
a cardiomyopathy characterized by diastolic dysfunction and
structural remodeling. Cardiac fibrosis is observed in many
models of diabetes. Thus, OVE26 mice modeling type 1
diabetes mellitus showed increased nuclear factor-κB and matrix
metalloproteinase (MMP) activities and cardiac fibrosis (Li et al.,
2011).
Leptin-deficient ob/ob mice modeling human diabetes
mellitus showed reduced pro-MMP-8, -9, and -13 gene
expression and increased stimulation of pro-collagen Iα,
resulting in cardiac fibrosis (Zibadi et al., 2011). Leptin receptor-
deficient db/db mice similarly show increased fibrosis (Cox
and Marsh, 2014). In diabetes, RyR2 gating is abnormal
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FIGURE 3 | Diseases leading to IAB.
FIGURE 4 | Potential molecular mechanisms leading to conduction abnormalities in IAB. RAS, renin-angiotensin system; Ang-II, angiotensin II; AT1R,
angiotensin II receptor isoform 1; NOX, NADPH oxidase; MAPK, mitogen-activated protein kinase; MCP-1, monocyte chemoattractant protein-1; MMP, matrix
metalloproteinase; MPTP, mitochondrial permeability transition pore; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; RANTES, Regulated on
Activation, Normal T Cell Expressed and Secreted; ROS, reactive oxygen species; RIRR, ROS-induced ROS release; TGF-β, transforming growth factor-beta; RyR2,
ryanodine receptor isoform 2.
due to channel oxidation by ROS (Eager et al., 1997; Xu
et al., 1998; Bidasee et al., 2003) and phosphorylation by
Ca2+/calmodulin-dependent protein kinase II (Witcher et al.,
1991; Hain et al., 1995; Wehrens et al., 2004), which
would lead to INa downregulation as discussed above. Taken
together, inflammation or infiltration lead to electrophysiological
remodeling of Na+ channel and gap junction downregulation, as
well as structural remodeling of fibrosis. Together, these produce
conduction abnormalities that underlie conduction block in
Bayés syndrome.
FUTURE PERSPECTIVE
Our understanding of Bayés syndrome has increased significantly
due to the development of mapping systems and the use
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of genetic and pharmacological mouse models for studying
cardiac electrophysiology. Despite its clinical significance, this
condition is under-diagnosed. Raising the awareness of IAB
in healthcare professionals could improve its diagnostic rates
(Baranchuk and Bayes de Luna, 2015). Risk stratification is
important for determining individuals who are most at risk of
cardiac arrhythmias (Tse, 2016a,b,c; Tse and Yan, 2016), and
should include patients with Bayés syndrome (Martinez-Selles
et al., 2016a). Measurement of magnetic fields in the heart has
been useful for characterizing cardiac structural abnormalities
(Vassiliou et al., 2014; Tse et al., 2015a,b), which can be useful
for detecting atrial fibrosis. Magnetocardiography can be used to
diagnose and predict the risk of cardiac arrhythmias in clinical
practice (Steinhoff et al., 2004; Kuijpers et al., 2011; Sato et al.,
2012; Kwong et al., 2013; Ito et al., 2014; Yoshida et al., 2015) and
has the potential for early detection of IAB (Jurkko et al., 2009).
IAB results in delayed and asynchronous activation of the
left atrium (Agarwal et al., 2003; Budeus et al., 2005; Caldwell
et al., 2014). IAB, particularly in its advanced form, is frequently
associated with supraventricular tachy-arrhythmias (Bayes de
Luna et al., 1999; Conde et al., 2015) and higher cardiovascular
and all-cause mortality (Ariyarajah et al., 2007c; Magnani et al.,
2011). The pathogenesis of AF in the context of IAB has
been studied in detail, demonstrating the occurrence of the
following event sequence: abnormal atrial activation can lead to
increased atrial pressure, with subsequent electrophysiological
and structural remodeling, such as atrial dilatation and fibrosis.
Furthermore, endothelial damage and dysfunction, together with
impaired atrial mechanical activity, is thrombogenic (Martinez-
Selles et al., 2016a). Regarding the optimal management of IAB
and AF, anti-arrhythmic treatment can reduce the recurrence
rate of atrial fibrillation (AF) associated with IAB (Bayes de
Luna et al., 1988, 1989). Anti-coagulation is needed to reduce
the risk of thrombo-embolic complications. Anti-coagulation is
likely to be beneficial for patients with IAB, even before the
development of AF (Martinez-Selles et al., 2016a). A recent paper
proposed that anticoagulation treatment should be initiated
based on the following criteria: P wave duration ≥ 160ms,
structural heart disease, >40 atrial premature beats/h and/or
runs in Holter monitoring and CHA2DS2-VASc score ≥ 2.
ACE inhibitors are now increasingly recognized for their anti-
fibrotic effects and trials should be conducted to determine
their relative efficacies in reducing arrhythmic risk, morbidity
and mortality in patients with IAB. Interventional management,
such as synchronous biatrial pacing, can be used to prevent the
recurrences of AF associated with IAB (D’Allonnes et al., 2000).
However, resynchronization therapymay be difficult in situations
such as hypertrophic cardiomyopathy or heart failure, where
patients will have abnormal cardiac hemodynamics. Thus, future
studies will be needed for its clarification.
AUTHOR CONTRIBUTIONS
GT: Design of manuscript; drafted and critically revised the
manuscript for important intellectual content; preparation of
figures. EL: Acquired and interpreted primary research papers;
critically revised the manuscript for important intellectual
content; preparation of figures. JY: Analyzed and interpreted
primary research papers; critically revised the manuscript for
important intellectual content. BY: drafted and critically revised
the manuscript for important intellectual content. All authors
approved the final version, ensured that the text is accurate and
agreed to be accountable for all aspects of the work.
ACKNOWLEDGMENTS
GT was awarded a BBSRC Doctoral Training Award at the
University of Cambridge for his PhD.
REFERENCES
Acar, G., Sayarlioglu, M., Akcay, A., Sokmen, A., Sokmen, G., Yalcintas, S., et al.
(2009). Evaluation of atrial electromechanical delay and left atrial mechanical
functions in patients with rheumatoid arthritis. Turk Kardiyol. Dern. Ars. 37,
447–453.
Agarwal, Y. K., Aronow, W. S., Levy, J. A., and Spodick, D. H. (2003). Association
of interatrial block with development of atrial fibrillation. Am. J. Cardiol. 91,
882. doi: 10.1016/S0002-9149(03)00027-4
Aragno, M., Mastrocola, R., Medana, C., Catalano, M. G., Vercellinatto, I., Danni,
O., et al. (2006). Oxidative stress-dependent impairment of cardiac-specific
transcription factors in experimental diabetes. Endocrinology 147, 5967–5974.
doi: 10.1210/en.2006-0728
Ariyarajah, V., Apiyasawat, S., Moorthi, R., and Spodick, D. H. (2006a). Potential
clinical correlates and risk factors for interatrial block.Cardiology 105, 213–218.
doi: 10.1159/000091642
Ariyarajah, V., Apiyasawat, S., Najjar, H., Mercado, K., Puri, P., and Spodick,
D. H. (2007a). Frequency of interatrial block in patients with sinus rhythm
hospitalized for stroke and comparison to those without interatrial block. Am.
J. Cardiol. 99, 49–52. doi: 10.1016/j.amjcard.2006.07.060
Ariyarajah, V., Asad, N., Tandar, A., and Spodick, D. H. (2005). Interatrial block:
pandemic prevalence, significance, and diagnosis. Chest 128, 970–975. doi:
10.1378/chest.128.2.970
Ariyarajah, V., Frisella, M. E., and Spodick, D. H. (2006b). Reevaluation
of the criterion for interatrial block. Am. J. Cardiol. 98, 936–937. doi:
10.1016/j.amjcard.2006.04.036
Ariyarajah, V., Kranis, M., Apiyasawat, S., and Spodick, D. H. (2007b). Potential
factors that affect electrocardiographic progression of interatrial block. Ann.
Noninvasive Electrocardiol. 12, 21–26. doi: 10.1111/j.1542-474X.2007.00134.x
Ariyarajah, V., Puri, P., Apiyasawat, S., and Spodick, D. H. (2007c). Interatrial
block: a novel risk factor for embolic stroke? Ann. Noninvasive Electrocardiol.
12, 15–20. doi: 10.1111/j.1542-474X.2007.00133.x
Asad, N., and Spodick, D. H. (2003). Prevalence of interatrial block in a
general hospital population. Am. J. Cardiol. 91, 609–610. doi: 10.1016/S0002-
9149(02)03320-9
Bachmann, G. (1916). The inter-auricular time interval. Am. J. Physiology – Legacy
Content 41, 309–320.
Bachmann, G. (1941). The significance of splitting of the P-wave in the
electrocardiogram∗ . Ann. Intern. Med. 14, 1702–1709. doi: 10.7326/0003-4819-
14-9-1702
Baranchuk, A., and Bayes de Luna, A. (2015). The P-wave morphology: what
does it tell us? Herzschrittmacherther. Elektrophysiol. 26, 192–199. doi:
10.1007/s00399-015-0385-3
Baranchuk, A., de Luna, A. B., and Breithardt, G. (2016). To the Editor— The role
of advanced interatrial block pattern as a predictor of atrial fibrillation. Heart
Rhythm 13, e87. doi: 10.1016/j.hrthm.2015.11.024
Frontiers in Physiology | www.frontiersin.org 6 May 2016 | Volume 7 | Article 188
Tse et al. Electrophysiological Mechanisms of Bayés Syndrome
Barr, R. C., Plonsey, R., and Johnson, C. R. (2003). Membrane current from
transmembrane potentials in complex core-conductor models. IEEE Trans.
Biomed. Eng. 50, 405–411. doi: 10.1109/TBME.2003.809508
Bayés de Luna, A. (1979). Bloqueo a nivel auricular. Rev. Esp. Cardiol. 39, 5.
Bayes de Luna, A., Cladellas, M., Oter, R., Torner, P., Guindo, J., Marti, V., et al.
(1988). Interatrial conduction block and retrograde activation of the left atrium
and paroxysmal supraventricular tachyarrhythmia. Eur. Heart J. 9, 1112–1118.
Bayes de Luna, A., Fort de Ribot, R., Trilla, E., Julia, J., Garcia, J., Sadurni, J.,
et al. (1985). Electrocardiographic and vectorcardiographic study of interatrial
conduction disturbances with left atrial retrograde activation. J. Electrocardiol.
18, 1–13. doi: 10.1016/S0022-0736(85)80029-7
Bayes de Luna, A., Guindo, J., Vinolas, X., Martinez-Rubio, A., Oter, R., and
Bayes-Genis, A. (1999). Third-degree inter-atrial block and supraventricular
tachyarrhythmias. Europace 1, 43–46. doi: 10.1053/eupc.1998.0006
Bayes de Luna, A., Oter, M. C., and Guindo, J. (1989). Interatrial conduction block
with retrograde activation of the left atrium and paroxysmal supraventricular
tachyarrhythmias: influence of preventive antiarrhythmic treatment. Int. J.
Cardiol. 22, 147–150. doi: 10.1016/0167-5273(89)90061-2
Bayes de Luna, A., Platonov, P., Cosio, F. G., Cygankiewicz, I., Pastore, C.,
Baranowski, R., et al. (2012). Interatrial blocks. A separate entity from left
atrial enlargement: a consensus report. J. Electrocardiol. 45, 445–451. doi:
10.1016/j.jelectrocard.2012.06.029
Beyer, E. C., Paul, D. L., and Goodenough, D. A. (1987). Connexin43: a protein
from rat heart homologous to a gap junction protein from liver. J. Cell Biol.
105, 2621–2629. doi: 10.1083/jcb.105.6.2621
Bidasee, K. R., Nallani, K., Besch, H. R. Jr., and Dincer, U. D. (2003).
Streptozotocin-induced diabetes increases disulfide bond formation on cardiac
ryanodine receptor (RyR2). J. Pharmacol. Exp. Ther. 305, 989–998. doi:
10.1124/jpet.102.046201
Boineau, J. (2005). The prolonged P wave and interatrial block. Time to consider a
broader concept and different terminology. J. Electrocardiol. 38, 327–329. doi:
10.1016/j.jelectrocard.2005.05.002
Budeus, M., Hennersdorf, M., Perings, C., Wieneke, H., Erbel, R., and
Sack, S. (2005). Prediction of the recurrence of atrial fibrillation
after successful cardioversion with P wave signal-averaged ECG. Ann.
Noninvasive Electrocardiol. 10, 414–419. doi: 10.1111/j.1542-474X.2005.
00059.x
Cagirci, G., Cay, S., Gulsoy, K. G., Bayindir, C., Vural, M. G., Firat, H., et al. (2011).
Tissue Doppler atrial conduction times and electrocardiogram interlead P-wave
durations with varying severity of obstructive sleep apnea. J. Electrocardiol. 44,
478–482. doi: 10.1016/j.jelectrocard.2011.03.009
Caldwell, J., Koppikar, S., Barake, W., Redfearn, D., Michael, K., Simpson, C.,
et al. (2014). Prolonged P-wave duration is associated with atrial fibrillation
recurrence after successful pulmonary vein isolation for paroxysmal atrial
fibrillation. J. Interv. Card. Electrophysiol. 39, 131–138. doi: 10.1007/s10840-
013-9851-1
Can, I., Aytemir, K., Demir, A. U., Deniz, A., Ciftci, O., Tokgozoglu, L., et al. (2009).
P-wave duration and dispersion in patients with obstructive sleep apnea. Int. J.
Cardiol. 133, e85–e89. doi: 10.1016/j.ijcard.2007.11.037
Chen, W., Potse, M., and Vinet, A. (2007). Dynamics of sustained reentry in a
loop model with discrete gap junction resistances. Phys. Rev. E Stat. Nonlin.
Soft Matter Phys. 76:021928. doi: 10.1103/PhysRevE.76.021928
Chen, Z., Sun, B., Tse, G., Jiang, J., and Xu, W. (in press). Reversibility of both
sinus node dysfunction and reduced HCN4 mRNA expression level in an
atrial tachycardia pacing model of tachycardia-bradycardia syndrome in rabbit
hearts. Int. J. Clin. Exp. Pathol. 9.
Chhabra, L., Devadoss, R., Chaubey, V. K., and Spodick, D. H. (2014).
Interatrial block in the modern era. Curr. Cardiol. Rev. 10, 181–189. doi:
10.2174/1573403X10666140514101748
Chhabra, L., Srinivasan, I., Sareen, P., Anand, C., and Spodick, D. H. (2012).
Interatrial block - a novel risk factor for acute mesenteric ischemia. Indian J.
Gastroenterol. 31, 191–194. doi: 10.1007/s12664-012-0194-0
Choy, L., Yeo, J. M., Tse, V., Chan, S. P., and Tse, G. (2016). Cardiac disease and
arrhythmogenesis: mechanistic insights from mouse models. Int. J. Cardiol.
Heart Vasc. 12, 1–10. doi: 10.1016/j.ijcha.2016.05.005
Chung, D. K., and Chung, E. K. (1972). Post-ectopic inhibition phenomenon. W.
V. Med. J. 68, 168–169.
Chung, E. K. (1970). Aberrant atrial conduction.W. V. Med. J. 66, 316–317.
Conde, D., and Baranchuk, A. (2014). Interatrial block as anatomical-electrical
substrate for supraventricular arrhythmias: Bayes syndrome. Arch. Cardiol.
Mex. 84, 32–40. doi: 10.1016/j.acmx.2013.10.004
Conde, D., Seoane, L., Gysel, M., Mitrione, S., Bayes de Luna, A., and Baranchuk,
A. (2015). Bayes’ syndrome: the association between interatrial block and
supraventricular arrhythmias. Expert Rev. Cardiovasc. Ther. 13, 541–550. doi:
10.1586/14779072.2015.1037283
Cosio, F. G., Martin-Penato, A., Pastor, A., Nunez, A., Montero, M. A., Cantale,
C. P., et al. (2004). Atrial activation mapping in sinus rhythm in the clinical
electrophysiology laboratory: observations during Bachmann’s bundle block. J.
Cardiovasc. Electrophysiol. 15, 524–531. doi: 10.1046/j.1540-8167.2004.03403.x
Cox, E. J., andMarsh, S. A. (2014). A systematic review of fetal genes as biomarkers
of cardiac hypertrophy in rodent models of diabetes. PLoS ONE 9:e92903. doi:
10.1371/journal.pone.0092903
Curran, J., and Louch, W. E. (2015). Linking ryanodine receptor Ca(2+) leak and
Na(+) current in heart: a day in the life of flecainide. Acta Physiol. (Oxf). 214,
300–302. doi: 10.1111/apha.12526
D’Allonnes, G. R., Pavin, D., Leclercq, C., Ecke, J. E., Jauvert, G., Mabo, P.,
et al. (2000). Long-term effects of biatrial synchronous pacing to prevent
drug-refractory atrial tachyarrhythmia: a nine-year experience. J. Cardiovasc.
Electrophysiol. 11, 1081–1091. doi: 10.1111/j.1540-8167.2000.tb01752.x
Daubert, J. C., Pavin, D., Jauvert, G., and Mabo, P. (2004). Intra- and interatrial
conduction delay: implications for cardiac pacing. Pacing Clin. Electrophysiol.
27, 507–525. doi: 10.1111/j.1540-8159.2004.00473.x
Dilaveris, P., Batchvarov, V., Gialafos, J., and Malik, M. (1999). Comparison
of different methods for manual P wave duration measurement in 12-
lead electrocardiograms. Pacing Clin. Electrophysiol. 22, 1532–1538. doi:
10.1111/j.1540-8159.1999.tb00358.x
Eager, K. R., Roden, L. D., and Dulhunty, A. F. (1997). Actions of sulfhydryl
reagents on single ryanodine receptor Ca(2+)-release channels from sheep
myocardium. Am. J. Physiol. 272, C1908–C1918.
Engelen, M. A., Juergens, K. U., Breithardt, G., and Eckardt, L. (2005). Interatrial
conduction delay and atrioventricular block due to primary cardiac lymphoma.
J. Cardiovasc. Electrophysiol. 16, 926. doi: 10.1046/j.1540-8167.2005.
50003.x
Enriquez, A., Marano, M., D’Amato, A., de Luna, A. B., and Baranchuk, A. (2015).
Second-degree interatrial block in hemodialysis patients. Case Rep. Cardiol.
2015:468493. doi: 10.1155/2015/468493
Fleg, J. L., and Strait, J. (2012). Age-associated changes in cardiovascular structure
and function: a fertile milieu for future disease. Heart Fail. Rev. 17, 545–554.
doi: 10.1007/s10741-011-9270-2
Fukui, A., Takahashi, N., Nakada, C., Masaki, T., Kume, O., Shinohara, T., et al.
(2013). Role of leptin signaling in the pathogenesis of angiotensin II-mediated
atrial fibrosis and fibrillation. Circ. Arrhythm. Electrophysiol. 6, 402–409. doi:
10.1161/CIRCEP.111.000104
Gan, R. Y., and Li, H. B. (2014). Recent progress on liver kinase B1 (LKB1):
expression, regulation, downstream signaling and cancer suppressive function.
Int. J. Mol. Sci. 15, 16698–16718. doi: 10.3390/ijms150916698
George, S. A., Sciuto, K. J., Lin, J., Salama, M. E., Keener, J. P., Gourdie, R.
G., et al. (2015). Extracellular sodium and potassium levels modulate cardiac
conduction in mice heterozygous null for the Connexin43 gene. Pflugers Arch.
467, 2287–2297. doi: 10.1007/s00424-015-1698-0
Gialafos, E., Psaltopoulou, T., Papaioannou, T. G., Synetos, A., Dilaveris,
P., Andrikopoulos, G., et al. (2007). Prevalence of interatrial block in
young healthy men <35 years of age. Am. J. Cardiol. 100, 995–997. doi:
10.1016/j.amjcard.2007.04.041
Gourdie, R. G., Green, C. R., Severs, N. J., Anderson, R. H., and Thompson, R.
P. (1993a). Evidence for a distinct gap-junctional phenotype in ventricular
conduction tissues of the developing and mature avian heart. Circ. Res. 72,
278–289. doi: 10.1161/01.RES.72.2.278
Gourdie, R. G., Severs, N. J., Green, C. R., Rothery, S., Germroth, P., and
Thompson, R. P. (1993b). The spatial distribution and relative abundance of
gap-junctional connexin40 and connexin43 correlate to functional properties
of components of the cardiac atrioventricular conduction system. J. Cell Sci.
105(Pt 4), 985–991.
Gramley, F., Lorenzen, J., Knackstedt, C., Rana, O. R., Saygili, E., Frechen, D., et al.
(2009). Age-related atrial fibrosis. Age (Dordr) 31, 27–38. doi: 10.1007/s11357-
008-9077-9
Frontiers in Physiology | www.frontiersin.org 7 May 2016 | Volume 7 | Article 188
Tse et al. Electrophysiological Mechanisms of Bayés Syndrome
Hagendorff, A., Schumacher, B., Kirchhoff, S., Lüderitz, B., andWillecke, K. (1999).
Conduction disturbances and increased atrial vulnerability in Connexin40-
deficient mice analyzed by transesophageal stimulation. Circulation 99,
1508–1515. doi: 10.1161/01.CIR.99.11.1508
Hain, J., Onoue, H., Mayrleitner, M., Fleischer, S., and Schindler, H. (1995).
Phosphorylation modulates the function of the calcium release channel of
sarcoplasmic reticulum from cardiac muscle. J. Biol. Chem. 270, 2074–2081.
doi: 10.1074/jbc.270.5.2074
Ito, Y., Shiga, K., Yoshida, K., Ogata, K., Kandori, A., Inaba, T., et al. (2014).
Development of a magnetocardiography-based algorithm for discrimination
between ventricular arrhythmias originating from the right ventricular outflow
tract and those originating from the aortic sinus cusp: a pilot study. Heart
Rhythm 11, 1605–1612. doi: 10.1016/j.hrthm.2014.05.032
Jairath, U. C., and Spodick, D. H. (2001). Exceptional prevalence of interatrial
block in a general hospital population. Clin. Cardiol. 24, 548–550. doi:
10.1002/clc.4960240805
James, T. N. (1963). The connecting pathways between the Sinus node and a-V
Node and between the right and the left atrium in the human heart. Am. Heart
J. 66, 498–508. doi: 10.1016/0002-8703(63)90382-X
Jurkko, R., Mantynen, V., Tapanainen, J. M., Montonen, J., Vaananen, H., Parikka,
H., et al. (2009). Non-invasive detection of conduction pathways to left atrium
using magnetocardiography: validation by intra-cardiac electroanatomic
mapping. Europace 11, 169–177. doi: 10.1093/europace/eun335
Kim, G. E., Ross, J. L., Xie, C., Su, K. N., Zaha, V. G., Wu, X., et al.
(2015). LKB1 deletion causes early changes in atrial channel expression and
electrophysiology prior to atrial fibrillation. Cardiovasc. Res. 108, 197–208. doi:
10.1093/cvr/cvv212
Kirchhof, P., Marijon, E., Fabritz, L., Li, N., Wang, W., Wang, T., et al.
(2013). Overexpression of cAMP-response elementmodulator causes abnormal
growth and development of the atrial myocardium resulting in a substrate
for sustained atrial fibrillation in mice. Int. J. Cardiol. 166, 366–374. doi:
10.1016/j.ijcard.2011.10.057
Kléber, A. G., and Rudy, Y. (2004). Basic mechanisms of cardiac impulse
propagation and associated arrhythmias. Physiol. Rev. 84, 431–488. doi:
10.1152/physrev.00025.2003
Kohl, P., and Gourdie, R. G. (2014). Fibroblast–myocyte electrotonic coupling:
does it occur in native cardiac tissue? J. Mol. Cell. Cardiol. 70, 37–46. doi:
10.1016/j.yjmcc.2013.12.024
Kuijpers, N. H., Potse, M., van Dam, P. M., ten Eikelder, H. M., Verheule, S.,
Prinzen, F. W., et al. (2011). Mechanoelectrical coupling enhances initiation
and affects perpetuation of atrial fibrillation during acute atrial dilation. Heart
Rhythm 8, 429–436. doi: 10.1016/j.hrthm.2010.11.020
Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., and Sadoshima,
J. (2010). NADPH oxidase 4 (Nox4) is a major source of oxidative stress
in the failing heart. Proc. Natl. Acad. Sci. U.S.A. 107, 15565–15570. doi:
10.1073/pnas.1002178107
Kwong, J. S., Leithauser, B., Park, J. W., and Yu, C. M. (2013). Diagnostic
value of magnetocardiography in coronary artery disease and cardiac
arrhythmias: a review of clinical data. Int. J. Cardiol. 167, 1835–1842. doi:
10.1016/j.ijcard.2012.12.056
Li, N., Chiang, D. Y., Wang, S., Wang, Q., Sun, L., Voigt, N., et al. (2014).
Ryanodine receptor-mediated calcium leak drives progressive development of
an atrial fibrillation substrate in a transgenic mouse model. Circulation 129,
1276–1285. doi: 10.1161/CIRCULATIONAHA.113.006611
Li, Y., Ma, J., Zhu, H., Singh, M., Hill, D., Greer, P. A., et al. (2011). Targeted
inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse
models of type 1 diabetes. Diabetes 60, 2985–2994. doi: 10.2337/db10-1333
Lorbar, M., Levrault, R., Phadke, J. G., and Spodick, D. H. (2005). Interatrial
block as a predictor of embolic stroke. Am. J. Cardiol. 95, 667–668. doi:
10.1016/j.amjcard.2004.10.059
Maeno, K., Kasai, T., Kasagi, S., Kawana, F., Ishiwata, S., Ohno, M., et al. (2013).
Relationship between atrial conduction delay and obstructive sleep apnea.
Heart Vessels 28, 639–645. doi: 10.1007/s00380-012-0288-8
Magnani, J. W., Gorodeski, E. Z., Johnson, V. M., Sullivan, L. M., Hamburg,
N. M., Benjamin, E. J., et al. (2011). P wave duration is associated
with cardiovascular and all-cause mortality outcomes: the National
Health and Nutrition Examination Survey. Heart Rhythm 8, 93–100. doi:
10.1016/j.hrthm.2010.09.020
Magnani, J. W., Johnson, V. M., Sullivan, L. M., Lubitz, S. A., Schnabel, R. B.,
Ellinor, P. T., et al. (2010). P-wave indices: derivation of reference values from
the Framingham Heart Study. Ann. Noninvasive Electrocardiol. 15, 344–352.
doi: 10.1111/j.1542-474X.2010.00390.x
Martinez-Selles, M., Fernandez Lozano, I., Baranchuk, A., Bayes-Genis, A.,
and Bayes de Luna, A. (2016a). Should we anticoagulate patients at high
risk of atrial fibrillation? Rev. Esp. Cardiol. (Engl. Ed). 69, 374–376. doi:
10.1016/j.rec.2016.01.008
Martinez-Selles, M., Masso-van Roessel, A., Alvarez-Garcia, J., Garcia de la Villa,
B., Cruz-Jentoft, A. J., Vidan, M. T., et al. (2016b). Interatrial block and atrial
arrhythmias in centenarians: prevalence, associations, and clinical implications.
Heart Rhythm 13, 645–651. doi: 10.1016/j.hrthm.2015.10.034
Mehrzad, R., and Spodick, D. H. (2014). Interatrial block: a virtual pandemic
requiring attention. Iran. J. Med. Sci. 39, 84–93.
Mizuno, R., Fujimoto, S., Nakano, H., Nakajima, T., Kimura, A., Nakagawa,
Y., et al. (1999). Atrial involvement in patients with progressive systemic
sclerosis: relationship between ultrasonic tissue characterization of the
atrium and interatrial conduction. Cardiology 91, 134–139. doi: 10.1159/0000
06893
Murugan, D., Lau, Y. S., Lau, W. C., Mustafa, M. R., and Huang, Y.
(2015). Angiotensin 1-7 protects against angiotensin II-induced endoplasmic
reticulum stress and endothelial dysfunction via mas receptor. PLoS ONE
10:e0145413. doi: 10.1371/journal.pone.0145413
Myrianthefs, M. M., Ellestad, M. H., Startt-Selvester, R. H., and Crump, R. (1991).
Significance of signal-averaged P-wave changes during exercise in patients with
coronary artery disease and correlation with angiographic findings. Am. J.
Cardiol. 68, 1619–1624. doi: 10.1016/0002-9149(91)90319-G
Nattel, S. (2008). Effects of heart disease on cardiac ion current density
versus current amplitude: important conceptual subtleties in the language
of arrhythmogenic ion channel remodeling. Circ. Res. 102, 1298–1300. doi:
10.1161/CIRCRESAHA.108.178087
Okutucu, S., Evranos, B., Aytemir, K., Kaya, E. B., Deveci, O. S., Deniz,
A., et al. (2010). Relationship between atrial septal aneurysms and atrial
electromechanical delay. Int. J. Cardiovasc. Imaging 27, 505–513. doi:
10.1007/s10554-010-9700-6
Peyrou, J., Park, C. I., Cikirikcioglu, M., Shah, D., and Muller, H. (2013). A rare
cause of Bachmann interatrial block. Eur. Heart J. Cardiovasc. Imaging 14, 1131.
doi: 10.1093/ehjci/jet099
Proietti, R., Mafrici, A., and Spodick, D. H. (2012). Dynamic variations of P-
wave duration in a patient with acute decompensated congestive heart failure.
Cardiol. J. 19, 95–97. doi: 10.5603/CJ.2012.0017
Qin, M., Huang, H., Wang, T., Hu, H., Liu, Y., Gu, Y., et al. (2012).
Atrial tachyarrhythmia in Rgs5-null mice. PLoS ONE 7:e46856. doi:
10.1371/journal.pone.0046856
Racker, D. K. (1989). Atrioventricular node and input pathways: a correlated
gross anatomical and histological study of the canine atrioventricular junctional
region. Anat. Rec. 224, 336–354. doi: 10.1002/ar.1092240303
Rhett, J. M., and Gourdie, R. G. (2012). The perinexus: a new feature
of Cx43 gap junction organization. Heart Rhythm 9, 619–623. doi:
10.1016/j.hrthm.2011.10.003
Rhett, J. M., Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2013). The
perinexus: sign-post on the path to a new model of cardiac conduction? Trends
Cardiovasc. Med. 23, 222–228. doi: 10.1016/j.tcm.2012.12.005
Rocken, C., Peters, B., Juenemann, G., Saeger, W., Klein, H. U., Huth,
C., et al. (2002). Atrial amyloidosis: an arrhythmogenic substrate
for persistent atrial fibrillation. Circulation 106, 2091–2097. doi:
10.1161/01.CIR.0000034511.06350.DF
Rohr, S. (2012). Arrhythmogenic implications of fibroblast-myocyte
interactions. Circulation Arrhythm. Electrophysiol. 5, 442–452. doi:
10.1161/circep.110.957647
Rohr, S., Kucera, J. P., and Kleber, A. G. (1998). Slow conduction in cardiac
tissue, I: effects of a reduction of excitability versus a reduction of electrical
coupling on microconduction. Circ. Res. 83, 781–794. doi: 10.1161/01.RES.
83.8.781
Sato, Y., Yoshida, K., Ogata, K., Inaba, T., Tada, H., Sekiguchi, Y., et al. (2012). An
increase in right atrial magnetic strength is a novel predictor of recurrence of
atrial fibrillation after radiofrequency catheter ablation. Circ. J. 76, 1601–1608.
doi: 10.1253/circj.CJ-11-1419
Frontiers in Physiology | www.frontiersin.org 8 May 2016 | Volume 7 | Article 188
Tse et al. Electrophysiological Mechanisms of Bayés Syndrome
Shang, L. L., and Dudley, S. C. Jr. (2005). Tandem promoters and developmentally
regulated 5′- and 3′-mRNA untranslated regions of the mouse Scn5a cardiac
sodium channel. J. Biol. Chem. 280, 933–940. doi: 10.1074/jbc.M409977200
Shang, L. L., Sanyal, S., Pfahnl, A. E., Jiao, Z., Allen, J., Liu, H., et al. (2008).
NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium
channel by angiotensin II. Am. J. Physiol. Cell Physiol. 294, C372–C379. doi:
10.1152/ajpcell.00186.2007
Smeets, J. L., Allessie, M. A., Lammers, W. J., Bonke, F. I., and Hollen, J. (1986).
The wavelength of the cardiac impulse and reentrant arrhythmias in isolated
rabbit atrium. The role of heart rate, autonomic transmitters, temperature, and
potassium. Circ Res. 58, 96–108. doi: 10.1161/01.RES.58.1.96
Song, J., Kalus, J. S., Caron, M. F., Kluger, J., and White, C. M. (2002). Effect of
diuresis on P-wave duration and dispersion. Pharmacotherapy 22, 564–568. doi:
10.1592/phco.22.8.564.33213
Sovari, A. A., Rutledge, C. A., Jeong, E. M., Dolmatova, E., Arasu, D., Liu,
H., et al. (2013). Mitochondria oxidative stress, connexin43 remodeling, and
sudden arrhythmic death. Circ. Arrhythm. Electrophysiol. 6, 623–631. doi:
10.1161/CIRCEP.112.976787
Spach, M. S., and Josephson, M. E. (1994). Initiating reentry: the role of
nonuniform anisotropy in small circuits. J. Cardiovasc. Electrophysiol. 5,
182–209. doi: 10.1111/j.1540-8167.1994.tb01157.x
Steinhoff, U., Knappe-Grueneberg, S., Schnabel, A., Trahms, L., Smith, F.,
Langley, P., et al. (2004). Magnetocardiography for pharmacology safety studies
requiring high patient throughput and reliability. J. Electrocardiol. 37(Suppl.),
187–192. doi: 10.1016/j.jelectrocard.2004.08.055
Szili-Torok, T., Akca, F., Caliskan, K., Ten Cate, F., Theuns, D., and Michels,
M. (2014). Extreme interatrial conduction delay and regularization of atrial
arrhythmias in a subgroup of patients with hypertrophic cardiomyopathy. IJC
Heart Vessels 4, 46–52.
Tapanainen, J. M., Jurkko, R., Holmqvist, F., Husser, D., Kongstad, O.,
Makijarvi, M., et al. (2009). Interatrial right-to-left conduction in patients with
paroxysmal atrial fibrillation. J. Interv. Card. Electrophysiol. 25, 117–122. doi:
10.1007/s10840-008-9359-2
Thilen, U., Carlson, J., Platonov, P. G., Havmoller, R., and Olsson, S. B. (2007).
Prolonged P wave duration in adults with secundum atrial septal defect: a
marker of delayed conduction rather than increased atrial size? Europace
9(Suppl. 6), vi105–vi108. doi: 10.1093/europace/eum214
Thomas, S. P., Kucera, J. P., Bircher-Lehmann, L., Rudy, Y., Saffitz, J. E., and
Kleber, A. G. (2003). Impulse propagation in synthetic strands of neonatal
cardiac myocytes with genetically reduced levels of connexin43. Circ. Res. 92,
1209–1216. doi: 10.1161/01.RES.0000074916.41221.EA
Thomsen, M. B., and Calloe, K. (2016). Human atrial fibroblasts and their
contribution to supraventricular arrhythmia. Physiol. Rep. 4:e12711. doi:
10.14814/phy2.12711
Tse, G. (2015). Mechanisms of cardiac arrhythmias. J Arrhythm. 32, 75–81. doi:
10.1016/j.joa.2015.11.003
Tse, G. (2016a). Both transmural dispersion of repolarization and transmural
dispersion of refractoriness are poor predictors of arrhythmogenicity: a role
for the index of Cardiac Electrophysiological Balance (QT/QRS)? J. Geriatr.
Cardiol.
Tse, G. (2016b). Novel conduction-repolarization indices for the stratification of
arrhythmic risk. J. Geriatr. Cardiol.
Tse, G. (2016c). (Tpeak-Tend)/QRS and (Tpeak-Tend)/(QT xQRS): novel markers
for predicting arrhythmic risk in Brugada syndrome. Europace.
Tse, G., Ali, A., Alpendurada, F., Prasad, S., Raphael, C. E., and Vassiliou, V.
(2015a). Tuberculous constrictive pericarditis. Res. Cardiovasc. Med. 4:e29614.
doi: 10.5812/cardiovascmed.29614
Tse, G., Ali, A., Prasad, S. K., Vassiliou, V., and Raphael, C. E. (2015b).
Atypical case of post-partum cardiomyopathy: an overlap syndrome with
arrhythmogenic right ventricular cardiomyopathy? BJR Case Rep. 1:20150182.
doi: 10.1259/bjrcr.20150182
Tse, G., Hothi, S. S., Grace, A. A., and Huang, C. L. (2012). Ventricular
arrhythmogenesis following slowed conduction in heptanol-treated,
Langendorff-perfused mouse hearts. J. Physiol. Sci. 62, 79–92. doi:
10.1007/s12576-011-0187-2
Tse, G., Lai, E. T., Tse, V., and Yeo, J. M. (2016a). Molecular and
electrophysiological mechanisms underlying cardiac arrhythmogenesis in
diabetes mellitus. J. Diabetes Res.
Tse, G., Lai, T. H., Yeo, J. M., Tse, V., and Wong, S. H. (2016b). Mechanisms of
electrical activation and conduction in the gastrointestinal system: lessons from
cardiac electrophysiology. Front. Physiol. 7:182. doi: 10.3389/fphys.2016.00182
Tse, G., Sun, B., Wong, S. T., Tse, V., and Yeo, J. M. (2016c). Ventricular anti-
arrhythmic effects of hypercalcaemia treatment in hyperkalaemic, Langendorff-
perfused mouse hearts. Biomed Rep. doi: 10.3892/br.2016.577
Tse, G., Tse, V., and Yeo, J. M. (2016d). Ventricular anti-arrhythmic effects of
heptanol in hypokalaemic, Langendorff-perfused mouse hearts. Biomed Rep.
4, 313–324. doi: 10.3892/br.2016.577
Tse, G., Tse, V., Yeo, J. M., and Sun, B. (2016e). Atrial anti-arrhythmic effects of
heptanol in Langendorff-perfused mouse hearts. PLoS ONE 11:e0148858. doi:
10.1371/journal.pone.0148858
Tse, G., Wong, S. T., Tse, V., Lee, Y. T., Lin, H. Y., and Yeo, J. M.
(2016f). Cardiac dynamics: alternans and arrhythmogenesis. J. Arrhythm. doi:
10.1016/j.joa.2016.02.009
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016g). Depolarization
vs.repolarization: what is the mechanism of ventricular arrhythmogenesis
underlying sodium channel haploinsufficiency in mouse hearts? Acta Physiol.
(Oxf). doi: 10.1111/apha.12694. [Epub ahead of print].
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (in press). Determination of action
potential wavelength restitution in Scn5a+/− mouse hearts modelling human
Brugada syndrome. J. Physiol.
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016h). Monophasic action potential
recordings: which is the recording electrode? J. Basic Clin. Physiol. Pharmacol.
doi: 10.1515/jbcpp-2016-0007. [Epub ahead of print].
Tse, G., Wong, S. T., Tse, V., and Yeo, J. M. (2016i). Restitution analysis of
alternans using dynamic pacing and its comparison with S1S2 restitution in
heptanol-treated, hypokalaemic Langendorff-perfused mouse hearts. Biomed
Rep. 4, 673–680. doi: 10.3892/br.2016.659
Tse, G., and Yan, B. P. (2016). Novel arrhythmic risk markers incorporating QRS
dispersion: QRSd x (Tpeak-Tend) / QRS and QRSd x (Tpeak-Tend)/(QT x
QRS). Ann. Noninvasive Electrocardiol.
Tse, G., and Yeo, J. M. (2015). Conduction abnormalities and ventricular
arrhythmogenesis: the roles of sodium channels and gap junctions. Int. J.
Cardiol. Heart Vasc. 9, 75–82. doi: 10.1016/j.ijcha.2015.10.003
Vaidya, D., Morley, G. E., Samie, F. H., and Jalife, J. (1999). Reentry and fibrillation
in the mouse heart. A challenge to the critical mass hypothesis. Circ. Res. 85,
174–181. doi: 10.1161/01.RES.85.2.174
van Rijen, H. V., van Veen, T. A., van Kempen,M. J.,Wilms-Schopman, F. J., Potse,
M., Krueger, O., et al. (2001). Impaired conduction in the bundle branches of
mouse hearts lacking the gap junction protein connexin40. Circulation 103,
1591–1598. doi: 10.1161/01.CIR.103.11.1591
Vassiliou, V., Chin, C., Perperoglou, A., Tse, G., Ali, A., Raphael, C., et al.
(2014). 93 ejection fraction by cardiovascular magnetic resonance predicts
adverse outcomes post aortic valve replacement. Heart 100, A53–A54. doi:
10.1136/heartjnl-2014-306118.93
Veeraraghavan, R., Lin, J., Hoeker, G. S., Keener, J. P., Gourdie, R. G., and Poelzing,
S. (2015). Sodium channels in the Cx43 gap junction perinexus may constitute
a cardiac ephapse: an experimental and modeling study. Pflugers Arch. 467,
2093–2105. doi: 10.1007/s00424-014-1675-z
Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2014a). Intercellular electrical
communication in the heart: a new, active role for the intercalated disk. Cell
Commun. Adhes. 21, 161–167. doi: 10.3109/15419061.2014.905932
Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2014b). Novel ligands
for zipping and unzipping the intercalated disk: today’s experimental tools,
tomorrow’s therapies? Cardiovasc. Res. 104, 229–230. doi: 10.1093/cvr/
cvu216
Veeraraghavan, R., Poelzing, S., and Gourdie, R. G. (2014c). Old cogs, new tricks:
a scaffolding role for connexin43 and a junctional role for sodium channels?
FEBS Lett. 588, 1244–1248. doi: 10.1016/j.febslet.2014.01.026
Veeraraghavan, R., Salama, M. E., and Poelzing, S. (2012). Interstitial
volume modulates the conduction velocity-gap junction relationship. Am.
J. Physiol. Heart Circ. Physiol. 302, H278–H286. doi: 10.1152/ajpheart.
00868.2011
Verheule, S., Sato, T., Everett, T. IV, Engle, S. K., Otten, D., Rubart-von der Lohe,
M., et al. (2004). Increased vulnerability to atrial fibrillation in transgenic mice
with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ. Res.
94, 1458–1465. doi: 10.1161/01.RES.0000129579.59664.9d
Frontiers in Physiology | www.frontiersin.org 9 May 2016 | Volume 7 | Article 188
Tse et al. Electrophysiological Mechanisms of Bayés Syndrome
Verheule, S., van Batenburg, C. A., Coenjaerts, F. E., Kirchhoff, S., Willecke, K., and
Jongsma, H. J. (1999). Cardiac conduction abnormalities in mice lacking the
gap junction protein connexin40. J. Cardiovasc. Electrophysiol. 10, 1380–1389.
doi: 10.1111/j.1540-8167.1999.tb00194.x
Vigmond, E. J. (2005). The electrophysiological basis of MAP recordings.
Cardiovasc. Res. 68, 502–503. doi: 10.1016/j.cardiores.2005.07.020
Vigmond, E. J., and Leon, L. J. (1999). Electrophysiological basis of mono-
phasic action potential recordings. Med. Biol. Eng. Comput. 37, 359–365. doi:
10.1007/BF02513313
Vigmond, E. J., Tsoi, V., Yin, Y., Page, P., and Vinet, A. (2009). Estimating atrial
action potential duration from electrograms. IEEE Trans. Biomed. Eng. 56,
1546–1555. doi: 10.1109/TBME.2009.2014740
Vollmann, D., Blaauw, Y., Neuberger, H.-R., Schotten, U., and Allessie, M.
(2005). Long-term changes in sequence of atrial activation and refractory
periods: No evidence for “atrial memory”. Heart Rhythm 2, 155–161. doi:
10.1016/j.hrthm.2004.11.013
Wehrens, X. H., Lehnart, S. E., Reiken, S. R., and Marks, A. R. (2004).
Ca2+/calmodulin-dependent protein kinase II phosphorylation
regulates the cardiac ryanodine receptor. Circ. Res. 94, e61–e70. doi:
10.1161/01.RES.0000125626.33738.E2
Wei, L. H., Huang, X. R., Zhang, Y., Li, Y. Q., Chen, H. Y., Heuchel, R., et al. (2013).
Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin
II infusion in a mouse model of hypertension. PLoS ONE 8:e70195. doi:
10.1371/journal.pone.0070195
Wiener, N., and Rosenblueth, A. (1946). The mathematical formulation of the
problem of conduction of impulses in a network of connected excitable
elements, specifically in cardiac muscle. Arch. Inst. Cardiol. Mex. 16, 205–265.
Willems, J. L., Robles de Medina, E. O., Bernard, R., Coumel, P., Fisch, C., Krikler,
D., et al. (1985). Criteria for intraventricular conduction disturbances and pre-
excitation. World Health Organizational/International Society and Federation
for Cardiology Task Force Ad Hoc. J. Am. Coll. Cardiol. 5, 1261–1275. doi:
10.1016/S0735-1097(85)80335-1
Witcher, D. R., Kovacs, R. J., Schulman, H., Cefali, D. C., and Jones, L. R. (1991).
Unique phosphorylation site on the cardiac ryanodine receptor regulates
calcium channel activity. J. Biol. Chem. 266, 11144–11152.
Xu, L., Eu, J. P., Meissner, G., and Stamler, J. S. (1998). Activation of the cardiac
calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science
279, 234–237. doi: 10.1126/science.279.5348.234
Yoshida, K., Ogata, K., Inaba, T., Nakazawa, Y., Ito, Y., Yamaguchi, I., et al. (2015).
Ability of magnetocardiography to detect regional dominant frequencies
of atrial fibrillation. J. Arrhythm. 31, 345–351. doi: 10.1016/j.joa.2015.
05.003
Zhang, H., Liu, J., Qu, D., Wang, L., Luo, J. Y., Lau, C. W., et al.
(2016). Inhibition of miR-200c restores endothelial function in diabetic
mice through suppression of COX-2. Diabetes 65, 1196–1207. doi: 10.2337/
db15-1067
Zhang, Y., Liu, J., Luo, J. Y., Tian, X. Y., Cheang, W. S., Xu, J., et al. (2015).
Upregulation of angiotensin (1-7)-mediated signaling preserves endothelial
function through reducing oxidative stress in diabetes. Antioxid. Redox Signal.
23, 880–892. doi: 10.1089/ars.2014.6070
Zibadi, S., Cordova, F., Slack, E. H., Watson, R. R., and Larson, D. F.
(2011). Leptin’s regulation of obesity-induced cardiac extracellular matrix
remodeling. Cardiovasc. Toxicol. 11, 325–333. doi: 10.1007/s12012-011-
9124-0
Zorov, D. B., Filburn, C. R., Klotz, L. O., Zweier, J. L., and Sollott, S. J. (2000).
Reactive oxygen species (ROS)-induced ROS release: a new phenomenon
accompanying induction of the mitochondrial permeability transition in
cardiac myocytes. J. Exp. Med. 192, 1001–1014. doi: 10.1084/jem.192.
7.1001
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Tse, Lai, Yeo and Yan. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 10 May 2016 | Volume 7 | Article 188
